comparemela.com

Latest Breaking News On - National stock exchange at rs - Page 3 : comparemela.com

bpcl stock update: BPCL ESPS Trust sells 0.3% stake in BPCL for around Rs 400 crore; several FPIs pick shares

The trust sold 68,36,948 shares at Rs 584 apiece, block deals data showed. Shares of the state-owned oil refiner ended 7.3% higher on the National Stock Exchange at Rs 626.95. Kotak Mahindra Mutual Fund purchased 22,50,000 shares at Rs 584 each, and Motilal Oswal MF acquired 13,00,000 shares at the same price.

India
Abu-dhabi
Abuz-aby
United-arab-emirates
Mumbai
Maharashtra
Bharat
Societe-generale
Abu-dhabi-investment-authority
Bharat-petroleum-corporation
Kotak-mahindra-life-insurance-co
Goldman-sachs

vedanta share price: Vedanta promoter in talks with GQG Partners to sell $1 billion worth stake: Report

The final talks for a potential stake sale have already taken place, and the transaction may take place in a few days in the form of a block deal, the news channel reported. As of December-end, promoter and group entities cumulatively held a 63.71% stake in Vedanta Ltd. On Wednesday, shares of Vedanta ended nearly 5% higher on the National Stock Exchange at Rs 282.55

Mumbai
Maharashtra
India
Adani-group
National-stock-exchange-at-rs
Vedanta-ltd
Hindenburg-research
Rajiv-jain-led
National-stock-exchange
Dalal-street
Anil-agarwal-led

Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growth

Mankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic revenue was led by robust growth in the chronic portfolio, recovery in anti-infectives and strong growth in modern trade and hospital sales.

Rajeev-juneja
Etmarkets-whatsapp
National-stock-exchange-at-rs
Mankind-pharma
National-stock-exchange
Economic-times
Mankind-pharma-q3-earnings
Mankind-pharma-q3
Mankind-pharma-q3-update
Mankind-pharma-q3fy24-earnings
Mankind-pharma-share-price
Mankind-pharma-stock-update

Dabur India Q3 Results: Consolidated PAT rises 8% YoY to Rs 514 crore

Dabur India Q3 Results: Consolidated revenue for the quarter increased 7% YoY to Rs 3,255 crore, which was also on expected lines. In constant currency (CC) terms, consolidated revenue grew by 10%, and the international business saw a nearly 12% growth. Sequentially, the consolidated topline rose just 1.6%, while the bottomline declined 0.2%.

Nigeria
Egypt
Turkey
India
Mumbai
Maharashtra
Mohit-malhotra
National-stock-exchange-at-rs
Dabur
Chief-executive-officer
Ayurvedic-ethicals
Home-care

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.